Skip to main content
Menu
Public Information Hub
About Us
BAPRAS Information
About plastic surgery
Patient Information
Procedure Guides
News and Views
Professionals
Training and Education
Prizes, grants and fellowships
Research
Clinical Guidance and Regulations
JPRAS & JPRAS Open
e-LPRAS
UK National Flap Registry
Become a Member
Training and Education
Upcoming courses and events
BAPRAS Events
About Us
Find a Unit
Find a Member
Member Log in
Search
Home
Media & Government
News and Views
Withdrawal of Macrolane for breast augmentation
Withdrawal of Macrolane for breast augmentation
23
rd
April 2012
On Friday 20 April 2012, the manufacturers Q-Med withdrew their injectable dermal filler Macrolane for use in breast augmentation.
BAPRAS Vice President Graeme Perks said:
“BAPRAS believes it is critical that every patient in the UK - whether being treated on the NHS or privately - is protected before, during and after their surgery. If there is any doubt about the safety and efficacy of a product it should not be used. We therefore support the withdrawal of the dermal filler Macrolane for breast augmentation.
"The recent examples of PIP breast implants and now Macrolane reiterate how important it is for cosmetic interventions to be properly regulated within the UK. We continue to work closely with the Department of Health to review current regulation and make recommendations for the future. We would to see a mandatory register for breast augmentation as part of this, with all types of ‘implant’ included.”
For further information on Macrolane, please see the MHRA and Q-Med websites:
http://www.mhra.gov.uk/NewsCentre/CON149797
http://www.q-med.com/press/News/April-2012/Q-MED-DISCONTINUES-THE-BREAST-INDICATION-FOR-MACROLANE/
Back to list page
News and Views